CRWD
CrowdStrike Holdings, Inc.
CRWD's fundamentals are strong, but it looks expensive: trading at 3678x earnings, about five times its usual 717x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CRWD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Unavailable |
CRWD's revenue and cash flow are currently healthy, and its profitability is stable. There isn't enough data to rate its balance sheet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CRWD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 153x | $230 | — |
| Cheap | 451x | $27.04 | -88% |
| Fair | 715x | $42.92 | -81% |
| Expensive | 3,337x | $200 | -13% |
| Current | 3,678x | $230 | — |
Historical ranges are pointers, not guarantees.
CRWD's PE is in its expensive range at 3678x. If earnings grow as analysts expect, today's price would be 153x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CRWD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Broad | |
| High |
CRWD has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CRWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.50 | +2400% |
| Q3 2026 | $0.06 | +$0.36 |
| Q2 2026 | -$0.03 | +$0.14 |
| Q1 2026 | -$0.16 | -$0.14 |
| Q4 2025 | -$0.32 | -346% |
| Q3 2025 | -$0.30 | -276% |
| Q2 2025 | -$0.17 | -221% |
| Q1 2025 | -$0.02 | -122% |
| Q4 2024 | $0.13 | +$0.15 |
CRWD has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CRWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +26% |
| Q2 2026 | $1.4B | +26% |
| Q1 2026 | $1.3B | +23% |
| Q4 2025 | $1.2B | +22% |
| Q3 2025 | $1.2B | +21% |
| Q2 2025 | $1.1B | +20% |
| Q1 2025 | $1.1B | +25% |
| Q4 2024 | $1B | +29% |
CRWD's revenue has grown year over year every quarter since late 2020: $1.5B last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.3% | +7.4 points |
| Q2 2026 | -2.2% | +9.1 points |
| Q1 2026 | 1.1% | +9.1 points |
| Q4 2025 | -5.6% | -0.1 points |
| Q3 2025 | -9.7% | -11 points |
| Q2 2025 | -11% | -12 points |
| Q1 2025 | -8.1% | -12 points |
| Q4 2024 | -5.5% | -5.9 points |
CRWD has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CRWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $405.9M | +34% |
| Q2 2026 | $493.3M | +65% |
| Q1 2026 | $395.4M | +53% |
| Q4 2025 | $314.1M | +27% |
| Q3 2025 | $302.3M | +5.2% |
| Q2 2025 | $298.4M | -11% |
| Q1 2025 | $258.5M | -12% |
| Q4 2024 | $247.4M | -1.9% |
CRWD has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CRWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +12.9M shares |
| 1 year | +4.5% | +44.8M shares |
| 3 years | +7.8% | +75.9M shares |
| 5 years | +15% | +139M shares |
| Available history | +28% | +228M shares |
CRWD has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $175.6M |
| Q1 2020 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CRWD Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CRWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.1 | Neutral |
| Stochastic | 49.1 | Neutral |
CRWD's weekly RSI is 55 (neutral) and its Stochastic is 49 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CRWD PE vs Technology Sector
| Metric | CRWD | Sector median | Relative |
|---|---|---|---|
| PE | 3,678x | 28x | 13,101% above |
| PE % | 91 | 35 | 56 pts above |
CRWD is trading at 3678x earnings, a 13101% premium to the Technology sector's median of 28x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CRWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $247.4 | 7.1% below |
| 20 week MA | $221.9 | 3.6% above |
| 50 week MA | $163.0 | 41% above |
| 100 week MA | $136.0 | 69% above |
| 200 week MA | $97.5 | 136% above |
CRWD has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CRWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.2 | $55.3 | +352% |
| 2021 | $55.3 | $52.9 | -4.3% |
| 2022 | $52.9 | $25.5 | -52% |
| 2023 | $25.5 | $63.8 | +150% |
| 2024 | $63.8 | $88.8 | +39% |
| 2025 | $88.8 | $120.3 | +36% |
| 2026 YTD | $120.3 | $229.9 | +91% |
CRWD has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.